临床数据显示,Kyverna Therapeutics在研疗法取得突破性进展——所有受试患者在24周观察期内均展现出肌无力日常生活活动量表和定量肌力测试评分的快速且持久的改善。
临床数据显示,Kyverna Therapeutics在研疗法取得突破性进展——所有受试患者在24周观察期内均展现出肌无力日常生活活动量表和定量肌力测试评分的快速且持久的改善。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.